Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration atropine at different dosing frequencies for myopia control
ChiCTR2300073459Phase 4Completed
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Feb 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia (5 arms), sponsored by Eye Hospital of Wenzhou Medical University. Primary endpoint: Equivalent spherical lens (spherical equivalent refraction). Started Feb 2023; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2300073459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073459.